日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial

抗PD-1一线霍奇金淋巴瘤治疗期间血清TARC动态变化:来自GHSG NIVAHL试验的分析

Plattel, Wouter J; Teesink, Sophie; Visser, Lydia; Voltin, Conrad-Amadeus; Kaul, Helen; Schlößer, Hans A; Kroesen, Bart-Jan; Kobe, Carsten; von Tresckow, Bastian; Borchmann, Peter; Diepstra, Arjan; Bröckelmann, Paul J

Working towards harmonization of clinical trial reporting in Hodgkin lymphoma.

致力于霍奇金淋巴瘤临床试验报告的统一化

Kobe Carsten, Armand Philippe, Borchmann Sven, Collins Graham P, Cottereau Anne-Segolene, Ferdinandus Justin, Herrera Alex F, Rossi Davide, Plattel Wouter J, Barrington Sally F, Hutchings Martin

Serum TARC: a biomarker for early detection or exclusion of relapse in classic Hodgkin lymphoma

血清TARC:经典霍奇金淋巴瘤复发早期检测或排除的生物标志物

Teesink, Sophie A; Visser, Lydia; Nijland, Marcel; Keijzer, Kylie; Niezink, Anne G H; Kroesen, Bart-Jan; van den Berg, Anke; Diepstra, Arjan; Plattel, Wouter J

Molecular profiling of cell-free DNA from classic Hodgkin lymphoma patients identifies potential prognostic clusters and corresponds with disease dynamics

对经典霍奇金淋巴瘤患者游离DNA进行分子谱分析,可识别潜在的预后簇,并与疾病动态相对应。

Veltmaat, Nick; Tan, Geok-Wee; Zhong, Yujie; Teesink, Sophie; Terpstra, Martijn; Bult, Johanna; Nijland, Marcel; Kluiver, Joost; Diepstra, Arjan; van den Berg, Anke; Plattel, Wouter J

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

多柔比星暴露与青少年和成人霍奇金淋巴瘤幸存者乳腺癌风险的关系

Neppelenbroek, Suzanne I M; Geurts, Yvonne M; Aleman, Berthe M P; Lugtenburg, Pieternella J; Rademakers, Saskia E; de Weijer, Roel J; Schippers, Maaike G A; Ta, Bastiaan D P; Plattel, Wouter J; Zijlstra, Josée M; van der Maazen, Richard W M; Nijziel, Marten R; Ong, Francisca; Schimmel, Erik C; Posthuma, Eduardus F M; Kersten, Marie José; Böhmer, Lara H; Muller, Karin; Koene, Harry R; Te Boome, Liane C J; Bilgin, Yavuz M; de Jongh, Eva; Janus, Cécile P M; van Leeuwen, Flora E; Schaapveld, Michael

Enteropathy-associated T-cell lymphoma: A population-based cohort study on incidence, treatment, and outcome in the Netherlands

肠病相关T细胞淋巴瘤:一项基于荷兰人群的队列研究,探讨其发病率、治疗和预后

Meeuwes, Frederik O; Brink, Mirian; Plattel, Wouter J; Vermaat, Joost S P; Kersten, Marie José; Wondergem, Mariëlle; Visser, Otto; van der Poel, Marjolein W M; Oostvogels, Rimke; Woei-A-Jin, F J Sherida H; Böhmer, Lara; Snijders, Tjeerd J F; Huls, Gerwin A; Nijland, Marcel

Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA

利用游离DNA进行移植后淋巴增殖性疾病的基因组分析

Veltmaat, Nick; Zhong, Yujie; de Jesus, Filipe Montes; Tan, Geok Wee; Bult, Johanna A A; Terpstra, Martijn M; Mutsaers, Pim G N J; Stevens, Wendy B C; Mous, Rogier; Vermaat, Joost S P; Chamuleau, Martine E D; Noordzij, Walter; Verschuuren, Erik A M; Kok, Klaas; Kluiver, Joost L; Diepstra, Arjan; Plattel, Wouter J; van den Berg, Anke; Nijland, Marcel

A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics

一项基于人群的转化型边缘区淋巴瘤研究:识别与预后相关的特征

Bult, Johanna A A; Huisman, Francien; Zhong, Yujie; Veltmaat, Nick; Kluiver, Joost; Tonino, Sanne H; Vermaat, Joost S P; Chamuleau, Martine E D; Diepstra, Arjan; van den Berg, Anke; Plattel, Wouter J; Brink, Mirian; Nijland, Marcel

T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors

T064:多柔比星暴露与青少年和成年霍奇金淋巴瘤幸存者乳腺癌风险

Mohaghegh, Fatemeh; Hatami, Parvaneh; Refaghat, Arezoo; Matini, Amir Hassan; Mohseni Afshar, Zeinab; Aryanian, Zeinab; Neppelenbroek, Suzanne IM; Geurts, Yvonne MG; Aleman, Berthe M P; Janus, Cécile PM; Lugtenburg, Pieternella J; Rademaker, Saskia E; De Weijer, Roel J; Schippers, Maaike GA; Ta, Bastiaan DP; Plattel, Wouter J; Zijlstra, Josée M; Van Der Maazen, Richard WM; Nijziel, Marten R; Ong, Francisca; Schimmel, Erik C; Posthuma, Eduardus FM; Kersten, Marie José; Böhmer, Lara H; Muller, Karin; Koene, Harry R; Te Boome, Liane CJ; Bilgin, Yavuz M; De Jongh, Eva; Van Leeuwen, Flora E; Schaapveld, Michael

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

将布伦妥昔单抗与地塞米松、大剂量阿糖胞苷和顺铂联合用于复发或难治性霍奇金淋巴瘤的挽救治疗:HOVON/LLPC Transplant BRaVE II期研究

Kersten, Marie José; Driessen, Julia; Zijlstra, Josée M; Plattel, Wouter J; Morschhauser, Franck; Lugtenburg, Pieternella J; Brice, Pauline; Hutchings, Martin; Gastinne, Thomas; Liu, Roberto; Burggraaff, Coreline N; Nijland, Marcel; Tonino, Sanne H; Arens, Anne I J; Valkema, Roelf; van Tinteren, Harm; Lopez-Yurda, Marta; Diepstra, Arjan; De Jong, Daphne; Hagenbeek, Anton